Australian biotech market today 28.04.09

By Kate McDonald
Tuesday, 28 April, 2009

The healthcare indices are up a very healthy 2.6 per cent on the market at 3.00pm on a day when other shares lost yesterday’s gains.

Biota (ASX:BTA) is down a touch following its massive rise yesterday, when shares shot up 80 per cent. It has settled at a very respectable $1.50 today.

Investors obviously like the look of any stocks with a whiff of swine flu, as vaccine developer CSL (ASX:CLS) is up $1.15 to $33.

In terms of the other majors, Cochlear (ASX:COH) is up $1 while ResMed (ASX:RMD) is up 3c.

Hexima (ASX:HXL) is up 3c to 45c – see our profile of the agbiotech company, published today.

Alchemia (ASX:ACL) is almost 19 per cent, while Mesoblast (ASX:MSB) is down 4c to 73c.

Related News

Less penicillin needed to treat Strep A infection than we thought

It's never been known exactly how much penicillin prevents sore throats — the most...

Stress disrupts emotion control in mental illness

Acute stress may impair key brain functions involved in managing emotions — particularly in...

Organoid platform enables closer study of bat-borne viruses

Reconstructing bat organ physiology in the lab lets scientists explore how zoonotic viruses work...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd